samedan logo
 
 
spacer
home > epc > winter 2001 > smos - creating a new outsourcing strategy for japanese pharmaceutical companies
PUBLICATIONS
European Pharmaceutical Contractor

SMOs - Creating a New Outsourcing Strategy for Japanese Pharmaceutical Companies

Japanese pharmaceutical companies wishing to conduct clinical research in Europe typically use contract research organisations (CROs), particularly those that offer 'full service' capabilities. Historically, this has been due to the fundamental fact that there is no alternative. Although some representative companies have sizeable clinical and regulatory departments, the majority of Japanese operations based in the UK or other European locations have a very small number of staff.

As a result, most global or multinational CROs have expended considerable effort in pursuing the attractive prospect of full service Japanese contracts, often in the hope that these will grow from single studies to full development programmes. In the very recent past, this has led to vigorous and expensive investment in operations and offices directly in Japan. This has been partly with a view to expanding their scope of work directly in the East, but also to improve the flow of projects and communications to their Western bases. Similarly, Japanese companies - wherever they are located - spend a considerable amount of time and resources debating and assessing the various strengths of the major CROs in performing certain studies.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Tristan Brittain-Dissont, Commercial Director at Intercern Clinical Research Solutions

Tristan Brittain-Dissont is one of the Founders of Intercern Clinical Research Solutions, which manages Europe's largest research network. Prior to launching the company, he spent 10 years in various companies within the pharmaceutical and clinical industries. During this time he worked at the contract research organisation Covance, where he headed a team of contract and business development specialists, working with clients on Phase II and III projects throughout the world. Before this he held positions with Biogen and Rhone Poulenc Rorer, where he worked closely with neurologists and neurology centres throughout Europe, in order to bring treatments for multiple sclerosis and motor neurone disease to market in the UK.

spacer
Tristan Brittain-Dissont
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

Discovery Summit 2010

22-24 March 2010, Cannes, France

The Discovery Summit 2010 will highlight the industry’s current challenges and opportunities on a global level through international keynote presentations and case studies delivered by the most esteemed thought leaders in the industry. 
More info >>

 
News and Press Releases

SCA Cool Logistics Announces Global Partnership with Minnesota Thermal Science

SCA Cool Logistics, a European market-leader of temperature-controlled packaging, would like to announce the strategic partnership with Minnesota Thermal Science (MTS), an international provider of solutions for the safe transportation of temperature sensitive pharmaceutical, blood and biologic products. The partnership will allow and SCA Cool Logistics and MTS to expand their operations globally, as well as offer a complete range of products to all clients.
More info >>

 

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement